Romero María Amparo, Seoane J, Varela-Centelles P, Diz-Dios P, Otero X L
Department of Stomatology, School of Medicine and Dentistry, University of Santiago de Compostela, Cantón Grande 5, E-15003 A Coruña, Spain.
Clin Otolaryngol Allied Sci. 2002 Feb;27(1):22-6. doi: 10.1046/j.0307-7772.2001.00516.x.
The reported prevalence rate of anti-hepatitis C virus (HCV) antibodies in patients with oral lichen planus shows wide geographical variation and ranges from 0 to 65%. Certain characteristic clinical features have been attributed to oral lichen planus associated to HCV infection. The purpose of this investigation has been to assess hypothetical clinical differences, as well as differences in the intensity of the subepithelial inflammatory infiltrate between oral lichen planus-HCV +ve patients and oral lichen planus-HCV -ve patients. A total of sixty-two patients entered the study. Their mean age was 63.5 +/- 14.49 years, and 48.4% of them were men and 51.6% women. Patients were classified according to their serum HCV positivity. Age, sex, clinical presentation (reticular or atrophic-erosive), extension of the lesions, location of the lesions, number of locations affected, intensity of the inflammatory infiltrate and Candida albicans colonization were recorded for each patient. Reticular lichen planus was the most frequent clinical presentation in both HCV +ve (57.1%) and HCV -ve patients (63.6%). C. albicans colonization ranged from 42.8% in HCV +ve and 41.7% in HCV -ve patients. HCV + ve patients showed certain oral locations more frequently affected than HCV -ve ones: lip mucosa, 28.6% versus 7.3%; tongue, 57.1% versus 29.1%; and gingiva, 71.4% versus 23.6%. The number of affected intraoral locations was higher in HCV +ve patients (71.4%) than among HCV -ve ones (20.4%; chi2 = 8.34; P < 0.011). No statistically significant differences could be established in terms of density of subepithelial inflammatory infiltrate between the groups. Our results reinforce the need for liver examination in all patients with oral lichen planus, particularly those showing lesions on the gingiva with multiple intraoral locations affected, as no pathological differences could be identified between HCV + ve and HCV -ve patients.
据报道,口腔扁平苔藓患者中抗丙型肝炎病毒(HCV)抗体的患病率存在广泛的地域差异,范围从0%至65%。某些特征性临床特征被归因于与HCV感染相关的口腔扁平苔藓。本研究的目的是评估口腔扁平苔藓-HCV阳性患者与口腔扁平苔藓-HCV阴性患者之间假设的临床差异,以及上皮下炎症浸润强度的差异。共有62名患者进入该研究。他们的平均年龄为63.5±14.49岁,其中48.4%为男性,51.6%为女性。患者根据血清HCV阳性情况进行分类。记录每位患者的年龄、性别、临床表现(网状或萎缩-糜烂型)、病变范围、病变部位、受累部位数量、炎症浸润强度和白色念珠菌定植情况。网状扁平苔藓是HCV阳性(57.1%)和HCV阴性患者(63.6%)中最常见的临床表现。白色念珠菌定植在HCV阳性患者中为42.8%,在HCV阴性患者中为41.7%。HCV阳性患者比HCV阴性患者某些口腔部位更常受累:唇黏膜,分别为28.6%和7.3%;舌,分别为57.1%和29.1%;牙龈,分别为71.4%和23.6%。HCV阳性患者口腔内受累部位的数量(71.4%)高于HCV阴性患者(20.4%;χ2 = 8.34;P < 0.011)。两组之间上皮下炎症浸润密度方面未发现统计学上的显著差异。我们的结果强化了对所有口腔扁平苔藓患者进行肝脏检查的必要性,特别是那些牙龈有病变且口腔内多个部位受累的患者,因为HCV阳性和HCV阴性患者之间未发现病理差异。